I thought they were going to treat for longer duration too. I thought Ligand had said years (in the plural) at a prior R&D day. They have their R&D day tomorrow I suspect it will at least get a passing mention but they usually don't give more details then their partners do.
i knew they were doing a ph2/3, but was very surprised to see this in mild to moderate AD. I had heard that this trial would be in MCI due to AD.
My estimate is that it will take them 6 months to enroll 200 subjects. I would bet they will take this from a ph 2 to ph 3 after they have 1 yr of safety and Biomarker data on ~100 patients. so maybe a switch to phase 3 within 1.5 years from now.
News 
Market Data 
Discover 
